- Meeting abstract
- Open Access
Does retrograde autologous priming of the cardiopulmonary bypass circuit have an impact on haematocrit and blood transfusion in uncomplicated coronary artery bypass graft surgery? A retrospective analysis
© Richards et al. 2015
- Published: 16 December 2015
- Cardiopulmonary Bypass
- Transfusion Requirement
- Blood Transfusion Requirement
- Haematocrit Level
- Allogenic Blood
Haemodilution occuring as a result of cardiopulmonary bypass prime volume increases the need for transfusion of allogenic blood products. Many techniques have been employed to reduce the same. Priming the CPB circuit with the patient's own blood is thought to decrease haemodilution and transfusion requirements.
We studied the impact of Retrograde Autologous Priming(RAP) of the CPB circuit in patients undergoing uncomplicated coronary artery surgery to assess haematocrit levels and transfusion needs.
We did a retrospective study on two groups of patients undergoing coronary artery bypass surgery over a six month period. In the non RAP group (n = 124), the CPB circuit was primed with crystalloid standard prime. In the RAP group (n = 120), retrograde autologous priming was used to reduce crystalloid prime (620.77 ml ± 133.13 ml). Haematocrit levels, transfusion requirements and other clinical parameters were evaluated.
Data collection from various databases in the hospital was done using Microsoft excel spreadsheet. Statistical analysis was performed using SPSS software for windows.
Demographic data and operative parameters were equal for patients in both groups.
The haematocrit levels pre CPB, lowest Hct on CPB and end of CPB were 37.9, 26.4, 27.43 in the RAP group compared to 41.35, 28.00, 28.36 in the Non RAP group.
Blood transfusion requirements in the RAP group was 0.84 and 0.80 in the Non RAP group. There was no significant difference in length of stay, post op AF.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.